nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—HTR2B—Raloxifene—osteoporosis	0.183	0.46	CbGbCtD
Pergolide—CYP3A4—Estropipate—osteoporosis	0.034	0.0855	CbGbCtD
Pergolide—CYP3A4—Calcitriol—osteoporosis	0.034	0.0855	CbGbCtD
Pergolide—CYP2D6—Cholecalciferol—osteoporosis	0.0276	0.0692	CbGbCtD
Pergolide—CYP3A4—Ergocalciferol—osteoporosis	0.0272	0.0683	CbGbCtD
Pergolide—CYP3A4—Raloxifene—osteoporosis	0.0227	0.057	CbGbCtD
Pergolide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0219	0.0551	CbGbCtD
Pergolide—CYP3A4—Cholecalciferol—osteoporosis	0.0175	0.044	CbGbCtD
Pergolide—CYP3A4—Conjugated Estrogens—osteoporosis	0.0161	0.0404	CbGbCtD
Pergolide—CYP3A4—Estradiol—osteoporosis	0.0141	0.0355	CbGbCtD
Pergolide—Oedema—Pamidronate—osteoporosis	0.000213	0.000441	CcSEcCtD
Pergolide—Infection—Pamidronate—osteoporosis	0.000212	0.000438	CcSEcCtD
Pergolide—Rhinitis—Estradiol—osteoporosis	0.000212	0.000438	CcSEcCtD
Pergolide—Hepatitis—Estradiol—osteoporosis	0.000211	0.000437	CcSEcCtD
Pergolide—Palpitations—Zoledronate—osteoporosis	0.000211	0.000436	CcSEcCtD
Pergolide—Abdominal pain—Calcitriol—osteoporosis	0.00021	0.000436	CcSEcCtD
Pergolide—Body temperature increased—Calcitriol—osteoporosis	0.00021	0.000436	CcSEcCtD
Pergolide—Shock—Pamidronate—osteoporosis	0.000209	0.000434	CcSEcCtD
Pergolide—Loss of consciousness—Zoledronate—osteoporosis	0.000209	0.000434	CcSEcCtD
Pergolide—Pharyngitis—Estradiol—osteoporosis	0.000209	0.000434	CcSEcCtD
Pergolide—Thrombocytopenia—Pamidronate—osteoporosis	0.000208	0.000432	CcSEcCtD
Pergolide—Vomiting—Etidronic acid—osteoporosis	0.000208	0.000431	CcSEcCtD
Pergolide—Cough—Zoledronate—osteoporosis	0.000208	0.000431	CcSEcCtD
Pergolide—Oedema peripheral—Estradiol—osteoporosis	0.000208	0.00043	CcSEcCtD
Pergolide—Tachycardia—Pamidronate—osteoporosis	0.000208	0.00043	CcSEcCtD
Pergolide—Rash—Etidronic acid—osteoporosis	0.000207	0.000428	CcSEcCtD
Pergolide—Convulsion—Zoledronate—osteoporosis	0.000206	0.000428	CcSEcCtD
Pergolide—Dermatitis—Etidronic acid—osteoporosis	0.000206	0.000427	CcSEcCtD
Pergolide—Vertigo—Conjugated Estrogens—osteoporosis	0.000206	0.000427	CcSEcCtD
Pergolide—Hyperhidrosis—Pamidronate—osteoporosis	0.000206	0.000426	CcSEcCtD
Pergolide—Syncope—Conjugated Estrogens—osteoporosis	0.000206	0.000426	CcSEcCtD
Pergolide—Hypertension—Zoledronate—osteoporosis	0.000206	0.000426	CcSEcCtD
Pergolide—Headache—Etidronic acid—osteoporosis	0.000205	0.000425	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000204	0.000423	CcSEcCtD
Pergolide—Asthenia—Estropipate—osteoporosis	0.000203	0.000421	CcSEcCtD
Pergolide—Visual impairment—Estradiol—osteoporosis	0.000203	0.000421	CcSEcCtD
Pergolide—Anorexia—Pamidronate—osteoporosis	0.000203	0.00042	CcSEcCtD
Pergolide—Chest pain—Zoledronate—osteoporosis	0.000203	0.00042	CcSEcCtD
Pergolide—Arthralgia—Zoledronate—osteoporosis	0.000203	0.00042	CcSEcCtD
Pergolide—Myalgia—Zoledronate—osteoporosis	0.000203	0.00042	CcSEcCtD
Pergolide—Palpitations—Conjugated Estrogens—osteoporosis	0.000203	0.00042	CcSEcCtD
Pergolide—Insomnia—Risedronate—osteoporosis	0.000203	0.00042	CcSEcCtD
Pergolide—Anxiety—Zoledronate—osteoporosis	0.000202	0.000419	CcSEcCtD
Pergolide—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000202	0.000418	CcSEcCtD
Pergolide—Paraesthesia—Risedronate—osteoporosis	0.000201	0.000417	CcSEcCtD
Pergolide—Pruritus—Estropipate—osteoporosis	0.000201	0.000415	CcSEcCtD
Pergolide—Discomfort—Zoledronate—osteoporosis	0.0002	0.000415	CcSEcCtD
Pergolide—Asthenia—Alendronate—osteoporosis	0.0002	0.000415	CcSEcCtD
Pergolide—Cough—Conjugated Estrogens—osteoporosis	0.0002	0.000415	CcSEcCtD
Pergolide—Dyspnoea—Risedronate—osteoporosis	0.0002	0.000414	CcSEcCtD
Pergolide—Hypotension—Pamidronate—osteoporosis	0.000199	0.000412	CcSEcCtD
Pergolide—Convulsion—Conjugated Estrogens—osteoporosis	0.000199	0.000412	CcSEcCtD
Pergolide—Dry mouth—Zoledronate—osteoporosis	0.000198	0.000411	CcSEcCtD
Pergolide—Pruritus—Alendronate—osteoporosis	0.000198	0.000409	CcSEcCtD
Pergolide—Dyspepsia—Risedronate—osteoporosis	0.000197	0.000408	CcSEcCtD
Pergolide—Eye disorder—Estradiol—osteoporosis	0.000197	0.000408	CcSEcCtD
Pergolide—Tinnitus—Estradiol—osteoporosis	0.000197	0.000407	CcSEcCtD
Pergolide—Constipation—Ethinyl Estradiol—osteoporosis	0.000196	0.000407	CcSEcCtD
Pergolide—Confusional state—Zoledronate—osteoporosis	0.000196	0.000406	CcSEcCtD
Pergolide—Chest pain—Conjugated Estrogens—osteoporosis	0.000195	0.000405	CcSEcCtD
Pergolide—Myalgia—Conjugated Estrogens—osteoporosis	0.000195	0.000405	CcSEcCtD
Pergolide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000195	0.000405	CcSEcCtD
Pergolide—Asthenia—Ibandronate—osteoporosis	0.000195	0.000404	CcSEcCtD
Pergolide—Anxiety—Conjugated Estrogens—osteoporosis	0.000195	0.000403	CcSEcCtD
Pergolide—Nausea—Etidronic acid—osteoporosis	0.000195	0.000403	CcSEcCtD
Pergolide—Oedema—Zoledronate—osteoporosis	0.000195	0.000403	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000194	0.000402	CcSEcCtD
Pergolide—Diarrhoea—Estropipate—osteoporosis	0.000194	0.000402	CcSEcCtD
Pergolide—Infection—Zoledronate—osteoporosis	0.000193	0.0004	CcSEcCtD
Pergolide—Insomnia—Pamidronate—osteoporosis	0.000193	0.000399	CcSEcCtD
Pergolide—Pruritus—Ibandronate—osteoporosis	0.000192	0.000398	CcSEcCtD
Pergolide—Pain—Risedronate—osteoporosis	0.000192	0.000397	CcSEcCtD
Pergolide—Constipation—Risedronate—osteoporosis	0.000192	0.000397	CcSEcCtD
Pergolide—Shock—Zoledronate—osteoporosis	0.000191	0.000396	CcSEcCtD
Pergolide—Paraesthesia—Pamidronate—osteoporosis	0.000191	0.000396	CcSEcCtD
Pergolide—Diarrhoea—Alendronate—osteoporosis	0.000191	0.000396	CcSEcCtD
Pergolide—Asthenia—Calcitriol—osteoporosis	0.000191	0.000395	CcSEcCtD
Pergolide—Thrombocytopenia—Zoledronate—osteoporosis	0.00019	0.000394	CcSEcCtD
Pergolide—Dyspnoea—Pamidronate—osteoporosis	0.00019	0.000393	CcSEcCtD
Pergolide—Tachycardia—Zoledronate—osteoporosis	0.00019	0.000393	CcSEcCtD
Pergolide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000189	0.000392	CcSEcCtD
Pergolide—Chills—Estradiol—osteoporosis	0.000189	0.000392	CcSEcCtD
Pergolide—Somnolence—Pamidronate—osteoporosis	0.000189	0.000392	CcSEcCtD
Pergolide—Pruritus—Calcitriol—osteoporosis	0.000188	0.00039	CcSEcCtD
Pergolide—Hyperhidrosis—Zoledronate—osteoporosis	0.000188	0.000389	CcSEcCtD
Pergolide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000188	0.000389	CcSEcCtD
Pergolide—Diarrhoea—Raloxifene—osteoporosis	0.000188	0.000389	CcSEcCtD
Pergolide—Dyspepsia—Pamidronate—osteoporosis	0.000187	0.000388	CcSEcCtD
Pergolide—Dizziness—Estropipate—osteoporosis	0.000187	0.000388	CcSEcCtD
Pergolide—Oedema—Conjugated Estrogens—osteoporosis	0.000187	0.000388	CcSEcCtD
Pergolide—Alopecia—Estradiol—osteoporosis	0.000186	0.000386	CcSEcCtD
Pergolide—Infection—Conjugated Estrogens—osteoporosis	0.000186	0.000385	CcSEcCtD
Pergolide—Diarrhoea—Ibandronate—osteoporosis	0.000186	0.000385	CcSEcCtD
Pergolide—Anorexia—Zoledronate—osteoporosis	0.000185	0.000384	CcSEcCtD
Pergolide—Decreased appetite—Pamidronate—osteoporosis	0.000185	0.000383	CcSEcCtD
Pergolide—Dizziness—Alendronate—osteoporosis	0.000185	0.000382	CcSEcCtD
Pergolide—Shock—Conjugated Estrogens—osteoporosis	0.000184	0.000382	CcSEcCtD
Pergolide—Gastrointestinal pain—Risedronate—osteoporosis	0.000183	0.000379	CcSEcCtD
Pergolide—Tachycardia—Conjugated Estrogens—osteoporosis	0.000183	0.000379	CcSEcCtD
Pergolide—Pain—Pamidronate—osteoporosis	0.000182	0.000377	CcSEcCtD
Pergolide—Constipation—Pamidronate—osteoporosis	0.000182	0.000377	CcSEcCtD
Pergolide—Diarrhoea—Calcitriol—osteoporosis	0.000182	0.000377	CcSEcCtD
Pergolide—Hypotension—Zoledronate—osteoporosis	0.000182	0.000376	CcSEcCtD
Pergolide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000182	0.000376	CcSEcCtD
Pergolide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000182	0.000376	CcSEcCtD
Pergolide—Dizziness—Raloxifene—osteoporosis	0.000182	0.000376	CcSEcCtD
Pergolide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000181	0.000375	CcSEcCtD
Pergolide—Flatulence—Estradiol—osteoporosis	0.000181	0.000375	CcSEcCtD
Pergolide—Tension—Estradiol—osteoporosis	0.00018	0.000373	CcSEcCtD
Pergolide—Vomiting—Estropipate—osteoporosis	0.00018	0.000373	CcSEcCtD
Pergolide—Dysgeusia—Estradiol—osteoporosis	0.00018	0.000372	CcSEcCtD
Pergolide—Dizziness—Ibandronate—osteoporosis	0.00018	0.000372	CcSEcCtD
Pergolide—Rash—Estropipate—osteoporosis	0.000179	0.00037	CcSEcCtD
Pergolide—Dermatitis—Estropipate—osteoporosis	0.000179	0.00037	CcSEcCtD
Pergolide—Anorexia—Conjugated Estrogens—osteoporosis	0.000179	0.00037	CcSEcCtD
Pergolide—Nervousness—Estradiol—osteoporosis	0.000178	0.000369	CcSEcCtD
Pergolide—Back pain—Estradiol—osteoporosis	0.000178	0.000368	CcSEcCtD
Pergolide—Headache—Estropipate—osteoporosis	0.000178	0.000368	CcSEcCtD
Pergolide—Vomiting—Alendronate—osteoporosis	0.000177	0.000368	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000177	0.000367	CcSEcCtD
Pergolide—Body temperature increased—Risedronate—osteoporosis	0.000177	0.000367	CcSEcCtD
Pergolide—Abdominal pain—Risedronate—osteoporosis	0.000177	0.000367	CcSEcCtD
Pergolide—Rash—Alendronate—osteoporosis	0.000176	0.000365	CcSEcCtD
Pergolide—Insomnia—Zoledronate—osteoporosis	0.000176	0.000364	CcSEcCtD
Pergolide—Dermatitis—Alendronate—osteoporosis	0.000176	0.000364	CcSEcCtD
Pergolide—Feeling abnormal—Pamidronate—osteoporosis	0.000175	0.000363	CcSEcCtD
Pergolide—Hypotension—Conjugated Estrogens—osteoporosis	0.000175	0.000362	CcSEcCtD
Pergolide—Headache—Alendronate—osteoporosis	0.000175	0.000362	CcSEcCtD
Pergolide—Paraesthesia—Zoledronate—osteoporosis	0.000175	0.000362	CcSEcCtD
Pergolide—Vomiting—Raloxifene—osteoporosis	0.000175	0.000361	CcSEcCtD
Pergolide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000174	0.000361	CcSEcCtD
Pergolide—Dyspnoea—Zoledronate—osteoporosis	0.000173	0.000359	CcSEcCtD
Pergolide—Rash—Raloxifene—osteoporosis	0.000173	0.000358	CcSEcCtD
Pergolide—Dermatitis—Raloxifene—osteoporosis	0.000173	0.000358	CcSEcCtD
Pergolide—Somnolence—Zoledronate—osteoporosis	0.000173	0.000358	CcSEcCtD
Pergolide—Vomiting—Ibandronate—osteoporosis	0.000173	0.000358	CcSEcCtD
Pergolide—Tremor—Estradiol—osteoporosis	0.000172	0.000356	CcSEcCtD
Pergolide—Headache—Raloxifene—osteoporosis	0.000172	0.000356	CcSEcCtD
Pergolide—Rash—Ibandronate—osteoporosis	0.000171	0.000355	CcSEcCtD
Pergolide—Dermatitis—Ibandronate—osteoporosis	0.000171	0.000355	CcSEcCtD
Pergolide—Dyspepsia—Zoledronate—osteoporosis	0.000171	0.000355	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000171	0.000353	CcSEcCtD
Pergolide—Ill-defined disorder—Estradiol—osteoporosis	0.00017	0.000353	CcSEcCtD
Pergolide—Headache—Ibandronate—osteoporosis	0.00017	0.000353	CcSEcCtD
Pergolide—Insomnia—Conjugated Estrogens—osteoporosis	0.000169	0.000351	CcSEcCtD
Pergolide—Vomiting—Calcitriol—osteoporosis	0.000169	0.00035	CcSEcCtD
Pergolide—Decreased appetite—Zoledronate—osteoporosis	0.000169	0.00035	CcSEcCtD
Pergolide—Agitation—Estradiol—osteoporosis	0.000169	0.00035	CcSEcCtD
Pergolide—Nausea—Estropipate—osteoporosis	0.000168	0.000349	CcSEcCtD
Pergolide—Abdominal pain—Pamidronate—osteoporosis	0.000168	0.000349	CcSEcCtD
Pergolide—Body temperature increased—Pamidronate—osteoporosis	0.000168	0.000349	CcSEcCtD
Pergolide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000168	0.000348	CcSEcCtD
Pergolide—Rash—Calcitriol—osteoporosis	0.000168	0.000347	CcSEcCtD
Pergolide—Dermatitis—Calcitriol—osteoporosis	0.000168	0.000347	CcSEcCtD
Pergolide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000167	0.000346	CcSEcCtD
Pergolide—Headache—Calcitriol—osteoporosis	0.000167	0.000345	CcSEcCtD
Pergolide—Somnolence—Conjugated Estrogens—osteoporosis	0.000166	0.000345	CcSEcCtD
Pergolide—Pain—Zoledronate—osteoporosis	0.000166	0.000344	CcSEcCtD
Pergolide—Constipation—Zoledronate—osteoporosis	0.000166	0.000344	CcSEcCtD
Pergolide—Nausea—Alendronate—osteoporosis	0.000166	0.000343	CcSEcCtD
Pergolide—Malaise—Estradiol—osteoporosis	0.000166	0.000343	CcSEcCtD
Pergolide—Vertigo—Estradiol—osteoporosis	0.000165	0.000342	CcSEcCtD
Pergolide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000165	0.000341	CcSEcCtD
Pergolide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000165	0.000341	CcSEcCtD
Pergolide—Syncope—Estradiol—osteoporosis	0.000165	0.000341	CcSEcCtD
Pergolide—Nausea—Raloxifene—osteoporosis	0.000163	0.000338	CcSEcCtD
Pergolide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000163	0.000337	CcSEcCtD
Pergolide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000163	0.000337	CcSEcCtD
Pergolide—Palpitations—Estradiol—osteoporosis	0.000162	0.000336	CcSEcCtD
Pergolide—Nausea—Ibandronate—osteoporosis	0.000161	0.000334	CcSEcCtD
Pergolide—Loss of consciousness—Estradiol—osteoporosis	0.000161	0.000334	CcSEcCtD
Pergolide—Asthenia—Risedronate—osteoporosis	0.000161	0.000333	CcSEcCtD
Pergolide—Feeling abnormal—Zoledronate—osteoporosis	0.00016	0.000332	CcSEcCtD
Pergolide—Cough—Estradiol—osteoporosis	0.00016	0.000332	CcSEcCtD
Pergolide—Constipation—Conjugated Estrogens—osteoporosis	0.00016	0.000332	CcSEcCtD
Pergolide—Pain—Conjugated Estrogens—osteoporosis	0.00016	0.000332	CcSEcCtD
Pergolide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000159	0.000329	CcSEcCtD
Pergolide—Hypertension—Estradiol—osteoporosis	0.000159	0.000328	CcSEcCtD
Pergolide—Pruritus—Risedronate—osteoporosis	0.000158	0.000328	CcSEcCtD
Pergolide—Nausea—Calcitriol—osteoporosis	0.000158	0.000327	CcSEcCtD
Pergolide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000157	0.000326	CcSEcCtD
Pergolide—Chest pain—Estradiol—osteoporosis	0.000156	0.000324	CcSEcCtD
Pergolide—Arthralgia—Estradiol—osteoporosis	0.000156	0.000324	CcSEcCtD
Pergolide—Myalgia—Estradiol—osteoporosis	0.000156	0.000324	CcSEcCtD
Pergolide—Anxiety—Estradiol—osteoporosis	0.000156	0.000323	CcSEcCtD
Pergolide—Discomfort—Estradiol—osteoporosis	0.000154	0.00032	CcSEcCtD
Pergolide—Abdominal pain—Zoledronate—osteoporosis	0.000154	0.000318	CcSEcCtD
Pergolide—Body temperature increased—Zoledronate—osteoporosis	0.000154	0.000318	CcSEcCtD
Pergolide—Diarrhoea—Risedronate—osteoporosis	0.000153	0.000317	CcSEcCtD
Pergolide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000153	0.000317	CcSEcCtD
Pergolide—Dry mouth—Estradiol—osteoporosis	0.000153	0.000317	CcSEcCtD
Pergolide—Asthenia—Pamidronate—osteoporosis	0.000153	0.000316	CcSEcCtD
Pergolide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000152	0.000315	CcSEcCtD
Pergolide—Confusional state—Estradiol—osteoporosis	0.000151	0.000313	CcSEcCtD
Pergolide—Pruritus—Pamidronate—osteoporosis	0.000151	0.000312	CcSEcCtD
Pergolide—Oedema—Estradiol—osteoporosis	0.00015	0.00031	CcSEcCtD
Pergolide—Infection—Estradiol—osteoporosis	0.000149	0.000308	CcSEcCtD
Pergolide—Dizziness—Risedronate—osteoporosis	0.000148	0.000307	CcSEcCtD
Pergolide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000148	0.000307	CcSEcCtD
Pergolide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000148	0.000307	CcSEcCtD
Pergolide—Shock—Estradiol—osteoporosis	0.000147	0.000305	CcSEcCtD
Pergolide—Tachycardia—Estradiol—osteoporosis	0.000146	0.000303	CcSEcCtD
Pergolide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000146	0.000302	CcSEcCtD
Pergolide—Diarrhoea—Pamidronate—osteoporosis	0.000146	0.000302	CcSEcCtD
Pergolide—Hyperhidrosis—Estradiol—osteoporosis	0.000145	0.0003	CcSEcCtD
Pergolide—Rash—Ethinyl Estradiol—osteoporosis	0.000145	0.0003	CcSEcCtD
Pergolide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000145	0.0003	CcSEcCtD
Pergolide—Headache—Ethinyl Estradiol—osteoporosis	0.000144	0.000298	CcSEcCtD
Pergolide—Vomiting—Risedronate—osteoporosis	0.000142	0.000295	CcSEcCtD
Pergolide—Rash—Risedronate—osteoporosis	0.000141	0.000292	CcSEcCtD
Pergolide—Dermatitis—Risedronate—osteoporosis	0.000141	0.000292	CcSEcCtD
Pergolide—Dizziness—Pamidronate—osteoporosis	0.000141	0.000292	CcSEcCtD
Pergolide—Headache—Risedronate—osteoporosis	0.00014	0.000291	CcSEcCtD
Pergolide—Asthenia—Zoledronate—osteoporosis	0.00014	0.000289	CcSEcCtD
Pergolide—Pruritus—Zoledronate—osteoporosis	0.000138	0.000285	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000137	0.000283	CcSEcCtD
Pergolide—Nausea—Ethinyl Estradiol—osteoporosis	0.000136	0.000283	CcSEcCtD
Pergolide—Insomnia—Estradiol—osteoporosis	0.000136	0.000281	CcSEcCtD
Pergolide—Vomiting—Pamidronate—osteoporosis	0.000135	0.00028	CcSEcCtD
Pergolide—Paraesthesia—Estradiol—osteoporosis	0.000135	0.000279	CcSEcCtD
Pergolide—Asthenia—Conjugated Estrogens—osteoporosis	0.000134	0.000278	CcSEcCtD
Pergolide—Rash—Pamidronate—osteoporosis	0.000134	0.000278	CcSEcCtD
Pergolide—Dermatitis—Pamidronate—osteoporosis	0.000134	0.000278	CcSEcCtD
Pergolide—Dyspnoea—Estradiol—osteoporosis	0.000134	0.000277	CcSEcCtD
Pergolide—Headache—Pamidronate—osteoporosis	0.000133	0.000276	CcSEcCtD
Pergolide—Somnolence—Estradiol—osteoporosis	0.000133	0.000276	CcSEcCtD
Pergolide—Diarrhoea—Zoledronate—osteoporosis	0.000133	0.000276	CcSEcCtD
Pergolide—Nausea—Risedronate—osteoporosis	0.000133	0.000276	CcSEcCtD
Pergolide—Pruritus—Conjugated Estrogens—osteoporosis	0.000133	0.000274	CcSEcCtD
Pergolide—Dyspepsia—Estradiol—osteoporosis	0.000132	0.000273	CcSEcCtD
Pergolide—Decreased appetite—Estradiol—osteoporosis	0.00013	0.00027	CcSEcCtD
Pergolide—Dizziness—Zoledronate—osteoporosis	0.000129	0.000266	CcSEcCtD
Pergolide—Constipation—Estradiol—osteoporosis	0.000128	0.000265	CcSEcCtD
Pergolide—Pain—Estradiol—osteoporosis	0.000128	0.000265	CcSEcCtD
Pergolide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000128	0.000265	CcSEcCtD
Pergolide—Nausea—Pamidronate—osteoporosis	0.000126	0.000262	CcSEcCtD
Pergolide—Dizziness—Conjugated Estrogens—osteoporosis	0.000124	0.000256	CcSEcCtD
Pergolide—Vomiting—Zoledronate—osteoporosis	0.000124	0.000256	CcSEcCtD
Pergolide—Feeling abnormal—Estradiol—osteoporosis	0.000124	0.000256	CcSEcCtD
Pergolide—Rash—Zoledronate—osteoporosis	0.000123	0.000254	CcSEcCtD
Pergolide—Gastrointestinal pain—Estradiol—osteoporosis	0.000123	0.000254	CcSEcCtD
Pergolide—Dermatitis—Zoledronate—osteoporosis	0.000123	0.000254	CcSEcCtD
Pergolide—Headache—Zoledronate—osteoporosis	0.000122	0.000252	CcSEcCtD
Pergolide—Vomiting—Conjugated Estrogens—osteoporosis	0.000119	0.000247	CcSEcCtD
Pergolide—Body temperature increased—Estradiol—osteoporosis	0.000118	0.000245	CcSEcCtD
Pergolide—Abdominal pain—Estradiol—osteoporosis	0.000118	0.000245	CcSEcCtD
Pergolide—Rash—Conjugated Estrogens—osteoporosis	0.000118	0.000245	CcSEcCtD
Pergolide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000118	0.000244	CcSEcCtD
Pergolide—Headache—Conjugated Estrogens—osteoporosis	0.000117	0.000243	CcSEcCtD
Pergolide—Nausea—Zoledronate—osteoporosis	0.000116	0.000239	CcSEcCtD
Pergolide—Nausea—Conjugated Estrogens—osteoporosis	0.000111	0.00023	CcSEcCtD
Pergolide—Asthenia—Estradiol—osteoporosis	0.000108	0.000223	CcSEcCtD
Pergolide—Pruritus—Estradiol—osteoporosis	0.000106	0.00022	CcSEcCtD
Pergolide—Diarrhoea—Estradiol—osteoporosis	0.000103	0.000212	CcSEcCtD
Pergolide—Dizziness—Estradiol—osteoporosis	9.91e-05	0.000205	CcSEcCtD
Pergolide—Vomiting—Estradiol—osteoporosis	9.53e-05	0.000197	CcSEcCtD
Pergolide—Rash—Estradiol—osteoporosis	9.45e-05	0.000196	CcSEcCtD
Pergolide—Dermatitis—Estradiol—osteoporosis	9.44e-05	0.000196	CcSEcCtD
Pergolide—Headache—Estradiol—osteoporosis	9.39e-05	0.000194	CcSEcCtD
Pergolide—Nausea—Estradiol—osteoporosis	8.9e-05	0.000184	CcSEcCtD
Pergolide—ADRA2C—Metabolism—ADCY5—osteoporosis	1.97e-05	0.000166	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	1.97e-05	0.000166	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—GPX1—osteoporosis	1.97e-05	0.000165	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—CYP19A1—osteoporosis	1.96e-05	0.000165	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IRS2—osteoporosis	1.96e-05	0.000165	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—LEP—osteoporosis	1.96e-05	0.000164	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—ADCY5—osteoporosis	1.96e-05	0.000164	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—ADCY5—osteoporosis	1.96e-05	0.000164	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IRS2—osteoporosis	1.93e-05	0.000162	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—SPP1—osteoporosis	1.92e-05	0.000161	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—LEP—osteoporosis	1.92e-05	0.000161	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—KL—osteoporosis	1.91e-05	0.000161	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—SPP1—osteoporosis	1.89e-05	0.000159	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—SPP1—osteoporosis	1.89e-05	0.000159	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—LEP—osteoporosis	1.89e-05	0.000158	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.88e-05	0.000158	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—KL—osteoporosis	1.88e-05	0.000158	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.87e-05	0.000157	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—POMC—osteoporosis	1.86e-05	0.000157	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—KL—osteoporosis	1.84e-05	0.000155	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IRS2—osteoporosis	1.84e-05	0.000155	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	1.84e-05	0.000154	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.83e-05	0.000154	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.83e-05	0.000154	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.82e-05	0.000153	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—MTHFR—osteoporosis	1.82e-05	0.000152	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—ESR1—osteoporosis	1.8e-05	0.000151	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—LEP—osteoporosis	1.8e-05	0.000151	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.8e-05	0.000151	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.79e-05	0.00015	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	1.77e-05	0.000148	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.75e-05	0.000147	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.75e-05	0.000147	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IRS2—osteoporosis	1.74e-05	0.000146	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—ESR1—osteoporosis	1.72e-05	0.000144	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IRS2—osteoporosis	1.71e-05	0.000144	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IRS2—osteoporosis	1.71e-05	0.000144	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—KL—osteoporosis	1.71e-05	0.000144	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.71e-05	0.000144	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SPP1—osteoporosis	1.71e-05	0.000144	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.71e-05	0.000143	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—LEP—osteoporosis	1.7e-05	0.000143	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.7e-05	0.000143	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—IDH2—osteoporosis	1.69e-05	0.000142	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IRS1—osteoporosis	1.68e-05	0.000141	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—POMC—osteoporosis	1.68e-05	0.000141	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.68e-05	0.000141	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—LEP—osteoporosis	1.68e-05	0.000141	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—LEP—osteoporosis	1.68e-05	0.000141	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.67e-05	0.00014	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	1.65e-05	0.000139	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.65e-05	0.000139	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—POMC—osteoporosis	1.65e-05	0.000138	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.64e-05	0.000138	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.64e-05	0.000138	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.63e-05	0.000137	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	1.62e-05	0.000136	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—ESR1—osteoporosis	1.62e-05	0.000136	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—POMC—osteoporosis	1.62e-05	0.000136	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.62e-05	0.000136	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—IL6—osteoporosis	1.62e-05	0.000136	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.61e-05	0.000135	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.61e-05	0.000135	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—ADCY5—osteoporosis	1.6e-05	0.000135	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—ESR1—osteoporosis	1.6e-05	0.000134	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—ESR1—osteoporosis	1.6e-05	0.000134	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ENO1—osteoporosis	1.6e-05	0.000134	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—GPX1—osteoporosis	1.6e-05	0.000134	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SPP1—osteoporosis	1.6e-05	0.000134	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.59e-05	0.000134	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.58e-05	0.000133	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6R—osteoporosis	1.58e-05	0.000133	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PSMA2—osteoporosis	1.58e-05	0.000132	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PSMA5—osteoporosis	1.58e-05	0.000132	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SPP1—osteoporosis	1.57e-05	0.000132	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IGF1—osteoporosis	1.56e-05	0.000131	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ACP5—osteoporosis	1.55e-05	0.00013	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—POMC—osteoporosis	1.55e-05	0.00013	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IRS2—osteoporosis	1.55e-05	0.00013	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IRS1—osteoporosis	1.51e-05	0.000127	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.51e-05	0.000127	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.51e-05	0.000127	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.5e-05	0.000126	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IRS1—osteoporosis	1.49e-05	0.000126	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IRS1—osteoporosis	1.49e-05	0.000126	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.49e-05	0.000125	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.49e-05	0.000125	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.48e-05	0.000125	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—MTHFR—osteoporosis	1.47e-05	0.000124	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.47e-05	0.000124	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—LEP—osteoporosis	1.46e-05	0.000123	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—POMC—osteoporosis	1.46e-05	0.000123	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—LEP—osteoporosis	1.45e-05	0.000122	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—POMC—osteoporosis	1.45e-05	0.000122	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SPP1—osteoporosis	1.45e-05	0.000122	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.44e-05	0.000121	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IRS2—osteoporosis	1.44e-05	0.000121	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.44e-05	0.000121	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—POMC—osteoporosis	1.44e-05	0.000121	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—POMC—osteoporosis	1.44e-05	0.000121	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—TPI1—osteoporosis	1.44e-05	0.000121	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.43e-05	0.00012	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6R—osteoporosis	1.42e-05	0.00012	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.42e-05	0.000119	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—LEP—osteoporosis	1.41e-05	0.000119	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6R—osteoporosis	1.4e-05	0.000118	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6R—osteoporosis	1.4e-05	0.000118	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IGF1—osteoporosis	1.4e-05	0.000118	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.4e-05	0.000117	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.39e-05	0.000117	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.39e-05	0.000117	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.39e-05	0.000117	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IGF1—osteoporosis	1.38e-05	0.000116	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IGF1—osteoporosis	1.38e-05	0.000116	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—P4HB—osteoporosis	1.35e-05	0.000114	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.35e-05	0.000113	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—ESR1—osteoporosis	1.35e-05	0.000113	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.34e-05	0.000113	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GAPDH—osteoporosis	1.33e-05	0.000112	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.33e-05	0.000112	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IRS2—osteoporosis	1.31e-05	0.00011	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.3e-05	0.000109	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.3e-05	0.000109	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.3e-05	0.000109	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.3e-05	0.000109	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—RAP1A—osteoporosis	1.29e-05	0.000109	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.29e-05	0.000108	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—LEP—osteoporosis	1.28e-05	0.000108	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.28e-05	0.000107	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—MYC—osteoporosis	1.27e-05	0.000107	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.27e-05	0.000106	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—TGFB1—osteoporosis	1.27e-05	0.000106	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.26e-05	0.000106	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—LEP—osteoporosis	1.26e-05	0.000106	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IRS1—osteoporosis	1.26e-05	0.000106	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—POMC—osteoporosis	1.25e-05	0.000105	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IGF1—osteoporosis	1.25e-05	0.000105	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—POMC—osteoporosis	1.25e-05	0.000105	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1.24e-05	0.000104	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.24e-05	0.000104	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.24e-05	0.000104	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ESR1—osteoporosis	1.22e-05	0.000103	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.22e-05	0.000103	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.22e-05	0.000102	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—POMC—osteoporosis	1.21e-05	0.000102	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.21e-05	0.000102	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.21e-05	0.000101	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.2e-05	0.000101	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.2e-05	0.000101	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—POMC—osteoporosis	1.19e-05	0.0001	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—IL6—osteoporosis	1.19e-05	0.0001	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6R—osteoporosis	1.18e-05	9.95e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.18e-05	9.91e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—POMC—osteoporosis	1.18e-05	9.91e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.17e-05	9.85e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IGF1—osteoporosis	1.17e-05	9.81e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6R—osteoporosis	1.17e-05	9.79e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IGF1—osteoporosis	1.15e-05	9.65e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.15e-05	9.64e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IRS1—osteoporosis	1.14e-05	9.61e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—IL6—osteoporosis	1.14e-05	9.56e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.13e-05	9.45e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.1e-05	9.26e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—POMC—osteoporosis	1.1e-05	9.25e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.1e-05	9.21e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—POMC—osteoporosis	1.08e-05	9.1e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6R—osteoporosis	1.07e-05	9.03e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—IL6—osteoporosis	1.07e-05	9.02e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—POMC—osteoporosis	1.06e-05	8.91e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IGF1—osteoporosis	1.06e-05	8.9e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—IL6—osteoporosis	1.06e-05	8.9e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—IL6—osteoporosis	1.06e-05	8.9e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.06e-05	8.88e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ENO1—osteoporosis	1.05e-05	8.78e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ADCY5—osteoporosis	1.04e-05	8.78e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.04e-05	8.76e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GPX1—osteoporosis	1.04e-05	8.75e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6R—osteoporosis	1.04e-05	8.7e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PSMA5—osteoporosis	1.03e-05	8.66e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PSMA2—osteoporosis	1.03e-05	8.66e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.02e-05	8.6e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IGF1—osteoporosis	1.02e-05	8.58e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—POMC—osteoporosis	9.86e-06	8.28e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MYC—osteoporosis	9.72e-06	8.17e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TGFB1—osteoporosis	9.7e-06	8.15e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6R—osteoporosis	9.62e-06	8.08e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—MTHFR—osteoporosis	9.61e-06	8.07e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—IL6—osteoporosis	9.56e-06	8.03e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IL6—osteoporosis	9.54e-06	8.02e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MYC—osteoporosis	9.52e-06	8e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TGFB1—osteoporosis	9.5e-06	7.98e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IGF1—osteoporosis	9.48e-06	7.97e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MYC—osteoporosis	9.37e-06	7.87e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TGFB1—osteoporosis	9.35e-06	7.85e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—IL6—osteoporosis	9.23e-06	7.75e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—IL6—osteoporosis	9.18e-06	7.71e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MYC—osteoporosis	8.94e-06	7.51e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—IL6—osteoporosis	8.93e-06	7.5e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TGFB1—osteoporosis	8.92e-06	7.49e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL6—osteoporosis	8.79e-06	7.38e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MYC—osteoporosis	8.43e-06	7.08e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TGFB1—osteoporosis	8.41e-06	7.07e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.36e-06	7.02e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MYC—osteoporosis	8.32e-06	6.99e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MYC—osteoporosis	8.32e-06	6.99e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TGFB1—osteoporosis	8.3e-06	6.97e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	8.3e-06	6.97e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6—osteoporosis	8.1e-06	6.81e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6—osteoporosis	7.97e-06	6.7e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6—osteoporosis	7.81e-06	6.56e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—POMC—osteoporosis	7.68e-06	6.46e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MYC—osteoporosis	7.51e-06	6.31e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	7.49e-06	6.3e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6—osteoporosis	7.31e-06	6.14e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6—osteoporosis	7.25e-06	6.09e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MYC—osteoporosis	7.25e-06	6.09e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TGFB1—osteoporosis	7.23e-06	6.08e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MYC—osteoporosis	7.21e-06	6.06e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TGFB1—osteoporosis	7.2e-06	6.05e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6—osteoporosis	7.16e-06	6.01e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6—osteoporosis	7.04e-06	5.92e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MYC—osteoporosis	7.02e-06	5.9e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	7e-06	5.88e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MYC—osteoporosis	6.91e-06	5.8e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	6.89e-06	5.79e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ADCY5—osteoporosis	6.83e-06	5.74e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GPX1—osteoporosis	6.81e-06	5.72e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6—osteoporosis	6.72e-06	5.65e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MYC—osteoporosis	6.37e-06	5.35e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TGFB1—osteoporosis	6.35e-06	5.34e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6—osteoporosis	6.34e-06	5.33e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—MTHFR—osteoporosis	6.28e-06	5.28e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MYC—osteoporosis	6.26e-06	5.26e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6—osteoporosis	6.25e-06	5.25e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6—osteoporosis	6.25e-06	5.25e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TGFB1—osteoporosis	6.25e-06	5.25e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MYC—osteoporosis	6.13e-06	5.15e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	6.12e-06	5.14e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MYC—osteoporosis	5.7e-06	4.79e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	5.69e-06	4.78e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6—osteoporosis	5.65e-06	4.74e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6—osteoporosis	5.45e-06	4.58e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6—osteoporosis	5.42e-06	4.56e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6—osteoporosis	5.27e-06	4.43e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6—osteoporosis	5.19e-06	4.36e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—POMC—osteoporosis	5.02e-06	4.22e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6—osteoporosis	4.79e-06	4.02e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6—osteoporosis	4.71e-06	3.96e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6—osteoporosis	4.61e-06	3.87e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6—osteoporosis	4.28e-06	3.6e-05	CbGpPWpGaD
